Effect of anti-adhesion barrier solution containing ciprofloxacin-hydrocortisone on abraded mucosa with otitis media

Chul Ho Jang1, Yong Beom Cho, Cheol Hee Choi

  • 1Department of Otolaryngology, Chonnam National University Medical School, Gwangju, South Korea. chulsavio@hanmail.net

Abstract

Insights

New middle ear (ME) packing agents containing antibiotics and steroids significantly improved healing in inflamed, abraded ME mucosa. This packing enhanced aeration and reduced mucosal thickening, suggesting its potential clinical utility.

Area of Science:

  • Otolaryngology
  • Biomaterials Science
  • Inflammation Research

Background:

  • Middle ear (ME) inflammation and mucosal abrasion present challenges in otologic surgery.
  • The anti-adhesive and anti-inflammatory effects of novel ME packing agents require investigation.

Purpose of the Study:

  • To evaluate the anti-inflammatory and anti-adhesive properties of antibiotic-steroid containing packing agents in an abraded ME mucosa model.
  • To compare the efficacy of different ME packing materials, including hyaluronic acid-carboxymethyl cellulose (HA-CMC) and HA-CMC with antibiotic-steroid.

Main Methods:

  • Otitis media was induced in guinea pigs using Pseudomonas aeruginosa lipopolysaccharide (LPS).
  • ME mucosa was abraded, and animals were assigned to four groups: no packing, HA-CMC packing, or antibiotic-steroid containing HA-CMC packing.
  • Otoendoscopy, auditory brainstem responses (ABRs), CT scans, light microscopy (LM), and scanning electron microscopy (SEM) were used for evaluation.

Main Results:

  • The antibiotic-steroid containing HA-CMC packing group demonstrated superior recovery of ME aeration and ABR thresholds.
  • Histopathological analysis revealed normalized mucosal thickening in the group treated with antibiotic-steroid containing HA-CMC.
  • CT and otoendoscopic findings supported improved healing in the antibiotic-steroid packing group.

Conclusions:

  • Middle ear packing with antibiotic-steroid containing soluble HA-CMC shows promise for treating inflamed and abraded ME mucosa.
  • This novel packing agent may offer significant benefits in promoting healing and restoring function in specific otologic conditions.